Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes

GLIA

Volumn 21, Issue 2, 1997, Pages 204-216

  Revuelta, Mati ^a   Venero, José L ^a   Machado, Alberto ^a   Cano, Josefina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Astrocytes; Axotomy; Dopamine; Medial forebrain bundle; Rat; Selegiline; Striatum; Substantia nigra

Indexed keywords

DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL COUNT; CYTOLOGY; DRUG EFFECT; ELECTROCHEMISTRY; ENZYMOLOGY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOSTRIATUM; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER TRANSECTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SUBSTANTIA NIGRA; WISTAR RAT;

ANIMALS; AXOTOMY; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; ELECTROCHEMISTRY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; NEOSTRIATUM; NERVE DEGENERATION; NERVE ENDINGS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SELEGILINE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0031260363     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199710)21:2<204::AID-GLIA4>3.0.CO;2-6     Document Type: Article

References (47)

1. Alexi, T. and Hefti, F. (1993) Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience, 55:903-918.
2. Ames, B.N., Shigenaga, M.K., and Hagen, T.M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90:7915-7922.
3. Beck, K.D., Knusel, B., and Hefti, F. (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience, 52:855-866.
4. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A., and Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature, 373:339-341.
5. Berry, M.D., Juorio, A.V., and Paterson, I.A. (1994) Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Progress in Neurobiol., 44:141-161.
6. Biagini, G., Zoli, M., Fuxe, K., and Agnati, L.F. (1993) L-deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain. NeuroReport, 4:955-958.
7. Biagini, G., Frasoldati, A., Fuxe, K., and Agnati, L.F. (1994) The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: Evidence for L-deprenyl-induced activation of reactive astrocytes. Neurochem. Int., 25:17-22.
8. Birkmayer, W., Knoll, J., Riederer, P., Youdim, M.B.H., Hars, V., and Marton, J. (1985) Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease. J. Neural Transm. 64:113-127.
9. Carrillo, M.C., Kanai, S., Nokubo, M., and Kitani, K. (1991) (-)Deprenyl induces activities of both Superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci., 48:517-521.
10. Carrillo, M.C., Kanai, S., Nokubo, M., Ivy, G.O., Sato, Y., and Kitani, K. (1992) (-)Deprenyl increases activities of Superoxide dismutase and catalase in striatum but not in hippocampus: The sex- and age-related differences in the optimal dose in the rat. Exp. Neurol., 116:286-294.
11. Crews, L.L. and Wigston, D.J. (1990) The dependance of motoneurons on their target muscle during postnatal development of the mouse. J. Neurosci., 10:1643-1653.
12. de la Cruz, C.P., Revilla, E., Steffen, V., Rodriguez-Gomez, J.A., Cano, J., and Machado, A. (1996a) Protection of the aged substantia nigra of the rat against oxidative damage by (-)deprenyl. Br. J. Pharmacol., 117:1756-1760.
13. de la Cruz, C.P., Revilla, E., Venero, J.L., Ayala, A., Cano, J., and Machado, A. (1996b) Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rats. Free Rad. Biol. Med., 20:53-61.
14. Du, X. and Iacovitti, L. (1995) Synergy between growth factors and transmitters required for catecholamine differentiation in brain neurons. J. Neurosci., 15:5420-5427.
15. Ferrari, G., Minozzi, M.C., Toffano, G., Leon, A., and Skaper, S.D. (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Devel. Biol., 133:140-147.
16. Gerfen, C.R., Herkenham, M., and Thibault, J. (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7:3915-3934.
17. Gilad, G. and Teis, D.J. (1978) Reversible reduction of tyrosine hydroxylase enzyme protein during the retrograde reaction in mesolimbic dopaminergic neurons. Brain Res., 149:141-153.
18. Goldstein, M. (1995) Long- and short-term regulation of tyrosine hydroxylase. In: Psychopharmacology: The Fourth Generation of Progress F.E. Bloom and D.J. Kupfer, eds. Raven Press, New York, pp. 189-195.
19. Heinonen, E.H. and Lammintausta, R. (1991) A review of the pharmacology of selegiline. Acta Neurol. Scand. 84, Suppl. 136:44-59.
20. Hynes, M.A., Poulsen, K., Armanini, M., Berkemeier, L., Phillips, H., and Rosenthal, A. (1994) Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res., 37:144-154.
21. Jackson, G.R., Apffel, L., Werrbach-Perez, K., and Perez-Polo, J.K. (1990) Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J. Neurosci. Res., 25:360-368.
22. Knoll, J. (1978) The possible mechanism of action of (-)deprenyl in Parkinson's disease. J. Neural. Transm., 43:177-198.
23. Knusel, B., Michel, P.P., Schwaber, J., and Hefti, F. (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, and the insulin-like growth factors. J. Neurosci. 10:558-570.
24. Knusel, B., Winslow, J.W., Rosenthal, A., Burton, L.E., Seid, D.P., Nikolics, K., and Hefti, F. (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. USA, 88:961-965.
25. Knusel, B., Beck, K.D., Winslow, J.W., Rosenthal, A., Burton, L.E., Widmer, H.R., Nikolics, K., and Hefti, F. (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic neurons but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci., 12:4391-4402.
26. Kopin, I.J. (1993) The pharmacology of Parkinson's disease therapy: An update. Annu. Rev. Pharmacol. Toxicol., 32:467-495.
27. Li, X.M., Juorio, A.V., Paterson, I.A., Zhu, M.Y., and Boulton, A.A. (1992) Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells. J. Neurochem., 59:2324-2327.
28. McMillian, M.K., Thai, L., Hong, J.S., O'Callagham, J.P., and Pennypacker, K.R. (1994) Brain injury in a dish: A model for reactive gliosis. Trends. Neurosci., 17:138-142.
29. Mytilineou, C. and Cohen, G. (1985) Deprenyl protects dopamine neurons from the neurotoxic effects of 1-methyl-4-phenylpyridinium ion. J. Neurochem., 45:1951-1953.
30. Nistico, G., Ciriolo, M.R., Fiskin, K., Iannone, M., Martino, A., and Rotilio, G. (1992) NGF restores decrease in catalase activity and increases Superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Rad. Biol. Med., 12:177-181.
31. Oreland, L., Arai, Y., and Stenstrom, A. (1983) The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation. Acta Neurol. Scand. Suppl., 95:81-85.
32. The Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med., 321:1364-1371.
33. Paxinos, G. and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
34. 3H]-tyrosine by charcoal. Life Sci.,39:2185-2189.
35. Rinne, J.O., Roytta, M., Paljarvi, L., Rummukainen, J., and Rinne, U.K. (1991) Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease. Neurology, 41:859-861.
36. Rodriguez-Gomez, J.A., and Venero, J.L., Vizuete, M.L., Cano, J., and Machado, A. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system. Mol. Brain. Res. (in press).
37. Roy, E. and Bedard, P.J. (1993) Deprenyl increases survival of rat foetal nigral neurons in culture. NeuroReport, 4:1183-1186.
38. Salo, P.T. and Tatton, W.G. (1992) Deprenyl reduces the death of motor neurons caused by axotomy. J. Neurosci. Res., 31:394-400.
39. Schulzer, M., Mak, E., and Calne, D.B. (1992) The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann. Neural., 32:795-798.
40. Shirao, T., Evinger, M.J., Iacovitti, L., and Reis, D.J. (1992) Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra. Neurosci. Lett., 141:208-212.
41. Simonian, N.A. and Coyle, J.T. (1996) Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:83-106.
42. Spina, M.B., Squinto, S.P., Miller, J., Lindsay, R.M., and Hyman, C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J. Neurochem., 59:99-106.
43. Tatton, W.G. and Greenwood, C.E. (1991) Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res., 30:666-672.
44. Tetrud, J.W. and Langston, J.W. (1989) The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science, 41:519-522.
45. Tipton, K.F. and Singer, T.P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem., 61:1191-1205.
46. Vizuete, M.L., Stoffen, V., Ayala, A., Cano, J., and Machado, A. (1993) Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum. Neurosci. Lett., 152:113-116.
47. Wu, R.M., Murphy, D.L., and Chiueh, C.C. (1995) Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity. J. Neural. Transm., 100:53-61.